Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | COLL | BCRX | ORKA | ||
| Company | Collegium Pharma | Biocryst Pharma Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.08 | 7.61 | 31.52 | ||
| High | 50.79 | 7.77 | 31.82 | ||
| Low | 49.21 | 7.52 | 31.14 | ||
| Latest | 49.62 | 7.72 | 31.47 | ||
| Change | -0.22 | +0.09 | -0.23 | ||
| % Change | -0.44% | +1.18% | -0.73% | ||
| Volume | 136,346 | 1,343,168 | 234,322 | ||
| 20-Day Average Volume | 496,525 | 3,744,801 | 653,362 | ||
| Previous Close | 49.84 | 7.63 | 31.70 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 48.49 | 7.54 | 30.36 | ||
| 20-Day Raw Stochastic | 75.20% | 60.61% | 80.21% | ||
| 20-Day Relative Strength | 68.67 | 56.24 | 58.44 | ||
| Weighted Alpha | +83.00 | -2.79 | +143.81 | ||
| Today's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.38% since 12/19/25 | +4.12% since 12/19/25 | -1.16% since 12/19/25 | ||
| Low | 48.28 on 12/22/25 | 7.35 on 12/22/25 | 30.05 on 12/22/25 | ||
| High | 50.79 on 12/29/25 | 7.76 on 12/29/25 | 32.64 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | +6.16% since 11/28/25 | +7.45% since 11/28/25 | +4.55% since 11/28/25 | ||
| Low | 45.82 on 12/02/25 | 7.01 on 12/01/25 | 26.73 on 12/02/25 | ||
| High | 50.79 on 12/29/25 | 8.17 on 12/04/25 | 32.64 on 12/23/25 | ||
| 3-Month | |||||
| %Chg | +43.35% since 09/29/25 | +2.19% since 09/29/25 | +63.14% since 09/29/25 | ||
| Low | 31.26 on 10/13/25 | 6.00 on 10/14/25 | 18.19 on 10/01/25 | ||
| High | 50.79 on 12/29/25 | 8.17 on 12/04/25 | 32.64 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +65.57% since 06/27/25 | -17.57% since 06/27/25 | +184.03% since 06/27/25 | ||
| Low | 29.19 on 08/01/25 | 6.00 on 10/14/25 | 10.97 on 07/01/25 | ||
| High | 50.79 on 12/29/25 | 9.47 on 06/30/25 | 32.64 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,575,492 | 1,607,939 | 1,534,565 | ||
| Shares Outstanding, K | 31,611 | 210,739 | 48,409 | ||
| Annual Sales | 631,450,000 | 450,710,000 | 0 | ||
| Annual Net Income | 69,190,000 | -88,880,000 | -83,720,000 | ||
| Last Quarter Sales | 209,360,000 | 159,400,000 | 0 | ||
| Last Quarter Net Income | 31,510,000 | 12,900,000 | -30,280,000 | ||
| 60-Month Beta | 0.61 | 0.91 | -0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.25 on 11/06/25 | 0.06 on 11/03/25 | -0.55 on 11/12/25 | ||
| Latest Earnings Date | 02/26/26 | 02/23/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 7.76 | 96.25 | 0.00 | ||